0001209191-23-037015.txt : 20230614 0001209191-23-037015.hdr.sgml : 20230614 20230614162124 ACCESSION NUMBER: 0001209191-23-037015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230612 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coelho Mary Theresa CENTRAL INDEX KEY: 0001720772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38716 FILM NUMBER: 231014392 MAIL ADDRESS: STREET 1: 52 SUNRISE PARK ROAD CITY: NEW HAMPTON STATE: NY ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gamida Cell Ltd. CENTRAL INDEX KEY: 0001600847 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 BUSINESS PHONE: 97226595666 MAIL ADDRESS: STREET 1: 5 NAHUM HAFZADI STREET CITY: JERUSALEM STATE: L3 ZIP: 95484 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-12 0 0001600847 Gamida Cell Ltd. GMDA 0001720772 Coelho Mary Theresa C/O GAMIDA CELL LTD. 116 HUNTINGTON AVENUE BOSTON MA 02116 0 1 0 0 Chief Financial Officer 0 Share Option (Right to Buy) 1.98 2023-06-12 4 A 0 10000 0.00 A 2033-06-11 Ordinary Shares 10000 10000 D This option vests on the earlier of (i) the date of the closing of a Merger/Sale (as such term is defined under the Issuer's 2017 Share Incentive Plan (as amended)), or (ii) May 22, 2024, so long as, prior to such date, (x) the Reporting Person has not terminated without cause the Reporting Person's Consulting Agreement (the "Agreement") with the Issuer or (y) the Issuer has not terminated the Agreement for breach (and such breach has not been cured). /s/ Joshua F. Patterson, Attorney-in-Fact 2023-06-14